Astrazeneca (AZN) Exchange Rate Effect (2009 - 2026)
Astrazeneca (AZN) posted quarterly Exchange Rate Effect of $9.0 million for Q2 2026, down 68.97% year-over-year from $29.0 million in Q2 2025, and up 150.0% quarter-over-quarter from -$18.0 million in Q1 2026.
Astrazeneca (AZN) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Astrazeneca's Exchange Rate Effect history runs 17 years deep, the most recent figure standing at $9.0 million for Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 68.97% year-over-year to $9.0 million; the TTM figure through Jun 2026 stood at -$17.0 million (down 230.77% YoY), while the FY2025 annual figure was $46.0 million, up 149.46% from the prior year.
- Exchange Rate Effect for Q2 2026 stood at $9.0 million, up from -$18.0 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $29.0 million in Q2 2025, with the low at -$61.0 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$10.0 million (2022), against an average of -$9.9 million.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect slumped 318.18% in 2024, then soared 583.33% in 2025.
- Astrazeneca's Exchange Rate Effect stood at -$26.0 million in 2022, then slumped by 38.46% to -$36.0 million in 2023, then slumped by 69.44% to -$61.0 million in 2024, then jumped by 106.56% to $4.0 million in 2025, then soared by 125.0% to $9.0 million in 2026.
- Business Quant data shows AZN's Exchange Rate Effect at $9.0 million in Q2 2026, -$18.0 million in Q1 2026, and $4.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.18 Bn | 632.42 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 470.31 Bn | 463.74 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 377.76 Bn | 370.62 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 303.30 Bn | 295.61 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Astrazeneca | 257.84 Bn | 252.94 Bn | 12.86 Bn | 9.00 Mn |
| 6 | Amgen | 236.85 Bn | 222.86 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.10 Bn | 178.92 Bn | 6.22 Bn | -19.00 Mn |
| 8 | Pfizer | 159.40 Bn | 147.70 Bn | 10.94 Bn | -4.00 Mn |
| 9 | Gsk | 106.36 Bn | 102.19 Bn | 8.24 Bn | - |
| 10 | Sanofi | 54.99 Bn | 47.61 Bn | 10.79 Bn | 11.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.00 Mn |
| Jun 30, 2026 | 9.00 Mn |
| Mar 31, 2026 | -18.00 Mn |
| Mar 31, 2026 | -18.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | -12.00 Mn |
| Sep 30, 2025 | -12.00 Mn |
| Jun 30, 2025 | 29.00 Mn |
| Jun 30, 2025 | 29.00 Mn |
| Mar 31, 2025 | 25.00 Mn |
| Mar 31, 2025 | 25.00 Mn |
| Dec 31, 2024 | -61.00 Mn |
| Dec 31, 2024 | -61.00 Mn |
| Sep 30, 2024 | 20.00 Mn |
| Sep 30, 2024 | 20.00 Mn |
| Jun 30, 2024 | -6.00 Mn |
| Jun 30, 2024 | -6.00 Mn |
| Mar 31, 2024 | -46.00 Mn |
| Mar 31, 2024 | -46.00 Mn |